Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Statement regarding Coronavirus

30 Mar 2020 07:00

RNS Number : 9511H
Crimson Tide PLC
30 March 2020
 

30 March 2020

 

Crimson Tide Plc 

("Crimson Tide" or the "Company")

Statement regarding Coronavirus

 

Crimson Tide updates the market on the effects of current events on its business.

A very large percentage of Crimson Tide's revenues are provided on a long term contracted subscription basis with a regular cash cycle. Many of the Company's clients are those in the front line of public services including healthcare, supermarkets and the rail industry.

The Company has recently made a COVID-19 mpro5 flow available for free to all NHS workers. This flow can be downloaded from app stores and is designed to handle on smartphone or tablet specific NHS procedures for cleaning hospital areas. The app is already being used by NHS staff and is another example of mpro5's flexibility in providing immediate solutions to business challenges. After the current crisis is over the Board feels that mpro5 will become more relevant than ever.

Crimson Tide has a strong balance sheet with a current positive cash balance of approximately £0.4m with no debt, save for finance leases on operating equipment, instalments upon which are paid monthly. The Company also has an undrawn overdraft facility of £0.25m.

Before current restrictions, Crimson Tide's staff worked from home once per week and all workers are equipped and used to working from home, where they are all currently busy supporting our clients. mpro5 and our internal operating systems and data are entirely in the Microsoft Cloud. There are currently no plans for redundancies or to furlough staff.

Crimson Tide has experienced negligible disruption to normal business patterns thus far and the Board is comfortable that, even on the basis of sensitised forecasts, the Company will remain well funded and operational for the rest of this year and beyond.

Executive Chairman Barrie Whipp commented "Firstly, we hope that this virus leaves us so that we can return to a new normal. Our hearts go out to sufferers and workers in the NHS, some of whom represent our clients. We urge NHS trusts to use the free version of mpro5 that we have made available for cleanliness flows. Our long-term subscription revenue means that we are steadfast in pursuing our strategy whilst supporting our staff and helping our clients in these challenging times".

For further information:

Crimson Tide plc

Barrie Whipp / Luke Jeffrey 01892 542 444

finnCap Ltd (Nominated Adviser and Broker)

Julian Blunt Corporate Finance 020 7220 0500

Andrew Burdis Corporate Broking

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDZGZFGRNGGZM
Date   Source Headline
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company
23rd Apr 202110:37 amRNSPDMR Dealings
23rd Apr 202110:36 amRNSHolding(s) in Company
22nd Apr 202111:45 amRNSResult of General Meeting and Total Voting Rights
20th Apr 20217:00 amRNSContract Win
1st Apr 20213:52 pmRNSResult of Placing
1st Apr 202112:01 pmRNSPlacing to raise up to £6.0 million
1st Apr 202112:00 pmRNSPreliminary Results
18th Mar 20217:00 amRNSContract Win
1st Feb 20219:28 amRNSHolding(s) in Company
28th Jan 20217:00 amRNSAppointment of Director
26th Jan 20217:00 amRNSPilot with World Federation of Haemophilia
18th Jan 20219:36 amRNSHolding(s) in Company
12th Jan 20214:07 pmRNSHolding(s) in Company
7th Jan 20212:30 pmRNSHolding(s) in Company
23rd Dec 202012:15 pmRNSClarification re Grant of Options
22nd Dec 202010:45 amRNSGrant of Options under the Company's EMI Scheme
4th Dec 202011:35 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSContract Wins
12th Nov 20204:27 pmRNSDirector/PDMR Shareholding
6th Nov 20201:15 pmRNSPDMR dealing
26th Oct 202010:08 amRNSHolding(s) in Company
5th Oct 20209:16 amRNSHolding(s) in Company
18th Sep 20207:00 amRNSInterim Results
14th Sep 20202:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.